Skip to content

TRICHERES PHARMA

Absorbed by DUVIPHAR on 27-02-2026 KBO/BCE: BE 0477.700.650

Lifetime

19 annual accounts with figures on one time axis, 23 filings since 2003
peak of €162,153 in 2022
€1,422▲ €2,635
lowest -€510,256 in 2023
€716▲ €1,985
peak of €419,160 in 2022
-€91,649▲ €716
€386,901▼ 0.8%
peak of 0.7 FTE in 2007
-not published
Board1 name since 2025
1 director
Documentsfilings and deeds
03-12-202559 days before the deadline
2025micro format
Gross margin from -€1,213 to €1,422Profit of €716, after a lossMerger proposal: to be absorbed by DUVIPHAR 30-12 resigns as director 20-06

Key points

from the 2025 annual accounts, the last ones filed

Equity

-€91,649 from €419,160 in 2022

Equity fell below zero in 2023.

Debts

€386,901 131% of the balance sheet
Financial debts 100%Taxes and wages 0%

Of this, €582 falls due within a year.

Filings

23 annual accounts since 2003
deadline20102020

Four of the last ten came late. The 2022 accounts came in latest, 56 days after the end of the period.

Board and ownership

Director
Board & ownership

Recent changes

Merger: absorbed by DUVIPHAR DUVIPHAR holds all the shares · General meeting of 25-02-2026 · Gazette deed
Merger proposal: to be absorbed by DUVIPHAR Gazette deed
resigns as director appointed as director · General meeting of 26-05-2025 · Gazette deed
1 manager resigning, 1 director reappointed resigns as manager · reappointed as director · acts as permanent representative · General meeting of 29-05-2020 · Gazette deed
All 42 events

Official details

Source: KBO
Status
Absorbed by DUVIPHARmerger by absorption, November 2025
Activity
“L'exploitation d'officine(s) de pharmacie” (deed in French)From the articles, 6 activitiesNo NACE code in the KBO
Financial year end
30 June
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 30-06-2025

≈ €11,000estimated
€295,252▼ 0.9%
Filing
Filed on 03-12-2025
Financials

Insights on TRICHERES PHARMA

Absorbed by DUVIPHAR in November 2025. The last annual accounts are for financial year 2025. The company was dissolved without liquidation.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about TRICHERES PHARMA

What is the company number of TRICHERES PHARMA?
The company number of TRICHERES PHARMA is 0477.700.650. The VAT number is the same number with BE in front: BE 0477.700.650.
What is the legal form of TRICHERES PHARMA?
The KBO register gives TRICHERES PHARMA the legal form “SRL”.
Is TRICHERES PHARMA still active?
No. Absorbed in a merger on 27-02-2026.Company details
What is the turnover of TRICHERES PHARMA?
The turnover in financial year 2025 is about €11,000. This figure is estimated from the gross margin of €1,422 and 7,102 comparable companies of the same size. It probably lies between €4,800 and €25,000. It is a rough estimate.Financials
Is TRICHERES PHARMA profitable?
In financial year 2025, TRICHERES PHARMA made a profit of €716.
Where can I find the annual accounts of TRICHERES PHARMA?
TRICHERES PHARMA filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.

Next steps

Keep this company with today's facts in a case file.